Apply for RFA FD 19 002
- The Department of Health and Human Services, Food and Drug Administration in the agriculture, consumer protection, food and nutrition sector is offering a public funding opportunity titled "Validating Human Stem Cell Cardiomyocyte Technology for Better Predictive Assessment of Drug-Induced Cardiac Toxicity (U01 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.103.
- This funding opportunity was created on Jan 31, 2019.
- Applicants must submit their applications by Apr 04, 2019.
- Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: State governments, City or township governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification).
Browse more opportunities from the same category: Agriculture, Consumer Protection, Food and Nutrition
Next opportunity: DRL FY18 Increasing Civilian Security in Nigeria
Previous opportunity: Hands on the Future: A Making and Computer Coding Skill-building Program for Women
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.Apply for RFA FD 19 002
Applicants also applied for:
Applicants who have applied for this opportunity (RFA FD 19 002) also looked into and applied for these:
|Funding Number||Funding Title|
|RFA FD 19 005||Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical Trials (U01) Clinical Trial Optional|
|RFA FD 19 014||Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical Trials (U01- Clinical Trial Required) Activity Code|
|RFA FD 19 008||Bioequivalence of Topical Products: Bioequivalence Considerations for Ungual, Scalp, Vaginal, Anal or Rectal Dosage Forms (U01 Clinical Trial Not Allowed)|
|RFA FD 19 009||Bioequivalence of Topical Products: Elucidating the Sensorial and Functional Characteristics of Compositionally Different Topical Formulations (U01 Clinical Trial Required)|
|RFA FD 19 010||Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Not Allowed)|
|RFA FD 19 003||Cooperative Agreement to Support the Illinois Institute of Technology's Institute for Food Safety and Health (U19 Clinical Trial Optional)|
|RFA FD 19 011||Enhancing Regulatory Science for the Risk Based Quality Assessment of Complex Products (U01) - Clinical Trials Optional|
|PAR 19 190||Advancing Post-Market Surveillance of High-Risk Facilities and Products through Signal detection, Data analysis, and the Review of the State of Quality (U01) Clinical Trial Optional|
|PAR 19 216||Advancing Manufacturing Processing and Control Strategies for Drug Substances and Drug Products (U01)- Clinical Trial Optional|
|RFA FD 19 021||Implementation of the Animal Feed Regulatory Program Standards (U18 Clinical Trial Not Allowed)|
|RFA FD 19 018||Maintenance and Enhancement of ISO/IEC 17025 Accreditation and Whole Genome Sequencing for State Food Testing Laboratories (U18 Clinical Trial Not Allowed)|
|RFA FD 19 020||Novel Approaches to Translational Evidence Generation to Advance Coordinated Registry Networks (CRNs) via Big Data Analytics Using Disparate Data Sources (U01 Clinical Trial Optional)|
|RFA FD 19 019||Cooperative Agreement to Support the World Trade Organization's (WTO) Standards and Trade Development Facility (STDF) (U01 Clinical Trial Not Allowed)|
|RFA FD 19 015||Renewal Application: Increasing the Quality and Efficiency of Clinical Trials (U18) Clinical Trial Required|
|RFA FD 19 013||Convener and organizer of activities and engagements focused on the development of medical products and related processes, surveillance, and policies relevant to ongoing public health activities. (U01) Clinical Trial Not Allowed|
|RFA FD 19 016||Renewal Application: Kidney Health Initiative (R18) Clinical Trials Optional|
|RFA FD 19 026||Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act (U01) Clinical Trials Not Allowed|
|RFA FD 19 025||Information Sharing System for State-Regulated Drug Compounding Activities (U01) Clinical Trial Not Allowed|
|RFA FD 19 027||Renewal Application: Critical Path Public Private Partnerships (U18) Clinical Trials Optional|
|RFA FD 19 022||Implementation of U.S. Food Safety Modernization Act - Identifying, Researching, and Implementing Alternative Methods to Expand the Reach across the Global Supply Chain (U01) - Clinical Trials Not Allowed|
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!Apply for Grants
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA FD 19 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.